Primate embryonic stem cell line
AssigneeWisconsin Alumni Research Foundation
InventorJames A. Thomson
Life of this patent
Estimating the term…
Abstract
A purified preparation of primate embryonic stem cells is disclosed. This preparation is characterized by the following cell surface markers: SSEA-1 (−); SSEA-4 (+); TRA-1-60 (+); TRA-1-81 (+); and alkaline phosphatase (+). In a particularly advantageous embodiment, the cells of the preparation are human embryonic stem cells, have normal karyotypes, and continue to proliferate in an undifferentiated state after continuous culture for eleven months. The embryonic stem cell lines also retain the ability, throughout the culture, to form trophoblast and to differentiate into all tissues derived from all three embryonic germ layers (endoderm, mesoderm and ectoderm). A method for isolating a primate embryonic stem cell line is also disclosed.
Claims6
A pluripotent primate embryonic stem cell line that (i) proliferates in an in vitro culture for over one year, (ii) maintains the potential to differentiate to derivatives of endoderm, mesoderm, and ectoderm tissues, (iii) is inhibited from differentiation when cultured on a fibroblast feeder layer, (iv) is negative for the SSEA-1 cell surface marker and positive for alkaline phosphatase and the SSEA-3, Tra-1-60, Tra-1-81, and SSEA-4 cell surface markers, and (v) forms teratomas and not teratocarcinomas when injected into an immuno-compromised mouse.
Dependencies are inferred from the claim text.